CN Patent

CN102670632A — 吡非尼酮在抑制皮肤瘢痕形成的医药用途

Assigned to Individual · Expires 2012-09-19 · 14y expired

What this patent protects

本发明涉及吡非尼酮或其衍生物在制备抑制皮肤瘢痕形成的医药产品中的应用，优选的，所述医药产品为局部使用的制剂，含有0.001％～10％重量的吡非尼酮和适宜的赋形剂，该产品为优选施用到皮肤上，任选地负载或浸渍于敷料中而形成活性敷料。本发明能抑制任何类型创伤或损伤而导致的皮肤瘢痕的产生，也可以抑制或预防橘皮组织的产生。

USPTO Abstract

本发明涉及吡非尼酮或其衍生物在制备抑制皮肤瘢痕形成的医药产品中的应用，优选的，所述医药产品为局部使用的制剂，含有0.001％～10％重量的吡非尼酮和适宜的赋形剂，该产品为优选施用到皮肤上，任选地负载或浸渍于敷料中而形成活性敷料。本发明能抑制任何类型创伤或损伤而导致的皮肤瘢痕的产生，也可以抑制或预防橘皮组织的产生。

Drugs covered by this patent

Patent Metadata

Patent number: CN102670632A
Jurisdiction: CN
Classification: —
Expires: 2012-09-19
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.